Literature DB >> 19074416

BAC transgenesis in human embryonic stem cells as a novel tool to define the human neural lineage.

Dimitris G Placantonakis1, Mark J Tomishima, Fabien Lafaille, Sabrina C Desbordes, Fan Jia, Nicholas D Socci, Agnes Viale, Hyojin Lee, Neil Harrison, Viviane Tabar, Lorenz Studer.   

Abstract

Human embryonic stem cells (hESCs) have enormous potential for applications in basic biology and regenerative medicine. However, harnessing the potential of hESCs toward generating homogeneous populations of specialized cells remains challenging. Here we describe a novel technology for the genetic identification of defined hESC-derived neural cell types using bacterial artificial chromosome (BAC) transgenesis. We generated hESC lines stably expressing Hes5::GFP, Dll1::GFP, and HB9::GFP BACs that yield green fluorescent protein (GFP)(+) neural stem cells, neuroblasts, and motor neurons, respectively. Faithful reporter expression was confirmed by cell fate analysis and appropriate transgene regulation. Prospective isolation of HB9::GFP(+) cells yielded purified human motor neurons with proper marker expression and electrophysiological activity. Global mRNA and microRNA analyses of Hes5::GFP(+) and HB9::GFP(+) populations revealed highly specific expression signatures, suggesting that BAC transgenesis will be a powerful tool for establishing expression libraries that define the human neural lineage and for accessing defined cell types in applications of human disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19074416     DOI: 10.1634/stemcells.2008-0884

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  42 in total

Review 1.  Using stem cells and iPS cells to discover new treatments for Parkinson's disease.

Authors:  Oliver Cooper; Penny Hallett; Ole Isacson
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

2.  Tracking differentiating neural progenitors in pluripotent cultures using microRNA-regulated lentiviral vectors.

Authors:  Rohit Sachdeva; Marie E Jönsson; Jenny Nelander; Agnete Kirkeby; Carolina Guibentif; Bernhard Gentner; Luigi Naldini; Anders Björklund; Malin Parmar; Johan Jakobsson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

3.  Generation of human embryonic stem cell reporter lines expressing GFP specifically in neural progenitors.

Authors:  Parinya Noisa; Alai Urrutikoetxea-Uriguen; Meng Li; Wei Cui
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

4.  What can pluripotent stem cells teach us about neurodegenerative diseases?

Authors:  Hynek Wichterle; Serge Przedborski
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

5.  Single-molecule analysis reveals changes in the DNA replication program for the POU5F1 locus upon human embryonic stem cell differentiation.

Authors:  Sherri S Schultz; Sabrina C Desbordes; Zhuo Du; Settapong Kosiyatrakul; Inna Lipchina; Lorenz Studer; Carl L Schildkraut
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

6.  Induced pluripotent stem cell technology for the study of human disease.

Authors:  Gabsang Lee; Lorenz Studer
Journal:  Nat Methods       Date:  2010-01       Impact factor: 28.547

7.  Derivation of genetically modified human pluripotent stem cells with integrated transgenes at unique mapped genomic sites.

Authors:  Eirini P Papapetrou; Michel Sadelain
Journal:  Nat Protoc       Date:  2011-08-04       Impact factor: 13.491

Review 8.  Technical challenges in using human induced pluripotent stem cells to model disease.

Authors:  Krishanu Saha; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

9.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

10.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.